Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metabolic Syndrome and Risk of Chronic Philadelphia Negative Myeloproliferative Neoplasms

NCT07814560 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT07814560
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07814560 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metabolic Syndrome and Risk of Chronic Philadelphia Negative Myeloproliferative Neoplasms
Lead sponsor
Assiut University
Phase
Observational
Overall status
Not yet recruiting
Start date
December 1, 2026
Completion date
January 1, 2028
Enrollment
313 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

philadelphia chromosome negative chronic myelogenous leukemia